Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pearl Mingmu eye drops for visual fatigue
ChiCTR2100050286Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Aug 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pearl mingmu in asthenopia, sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Change in visual fatigue scale score from baseline and Change in corneal fluorescein staining score from baseline. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
pearl mingmu
03
Conditions
asthenopia
Beyond the preview
Go deeper on ChiCTR2100050286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050286.